Quintiles President & COO John Ratliff to Leave Company at End of 2013 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)

President & COO John Ratliff to Leave Company at End of 2013

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--October 31,

2013--Quintiles today announced that John Ratliff has resigned his

position as president and chief operating officer (COO) effective

December 31, 2013. He has also resigned his role as a member of the

Quintiles Transnational Holdings Inc. board of directors.

"On behalf of our board of directors, senior Quintiles management team

and our employees around the world, I would like to thank John Ratliff

for his leadership and tireless dedication to Quintiles over the past

nine years," said CEO Tom Pike. "Quintiles is known for its strong

management team, and I'm confident that these executives will ensure a

smooth transition for our customers, employees and the patients we

ultimately serve. John helped to grow this team as Quintiles has grown.

We wish him well in his future endeavors."

Ratliff joined Quintiles as chief financial officer in 2004, shortly

after the company began its transition from public to private ownership

in 2003. In 2006, he was named chief operating officer and was appointed

to Quintiles' board.

"Quintiles is a special company where I have had a tremendous

experience, both professionally and personally for almost a decade,"

Ratliff said. "The difference this company has made in people's lives is

truly amazing, and I am extremely proud to have played a part in it. I

love Quintiles and wish the best of luck to the entire organization,"

Quintiles (NYSE: Q) is the world's largest provider of biopharmaceutical

development and commercial outsourcing services with a network of more

than 28,000 employees conducting business in approximately 100

countries. We have helped develop or commercialize all of the top-50

best-selling drugs on the market. Quintiles applies the breadth and

depth of our service offerings along with extensive therapeutic,

scientific and analytics expertise to help our customers navigate an

increasingly complex healthcare environment as they seek to improve

efficiency and effectiveness in the delivery of better healthcare

outcomes. To learn more about Quintiles, please visit www.quintiles.com.

Click here to subscribe to Mobile Alerts for Quintiles.

Phil Bridges, + 1-919-998-1653

Mobile: +1-919-457-6347

Deonanan, +1-919-998-2789